Restrospective Multicenter Study Evaluating Efficacy And Safety Of Dasatinib And Nilotinib In Patients With Imatinib-Resistant Or -Intolerant Chronic Myeloid Leukemia In Chronic Phase: Korean Cml Working Party
BLOOD（2012）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要